{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:28:34Z","timestamp":1788413314936,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ando.2021.11.008","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T12:05:57Z","timestamp":1638533157000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Postoperative remission of non-invasive lactotroph pituitary tumor: A single-center experience"],"prefix":"10.1016","volume":"83","author":[{"given":"H\u00e9l\u00e8ne","family":"Lasolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Teulade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Lapras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vasiljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jouanneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2021.11.008_bib0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0205","first-page":"105","article-title":"Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis","author":"Zamanipoor Najafabadi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2009-1238","article-title":"Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis","volume":"95","author":"Dekkers","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0215","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2021.11.008_bib0220","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1210\/jc.2016-2224","article-title":"A follow-up study of the prevalence of valvular heart abnormalities in hyperprolactinemic patients treated with cabergoline","volume":"101","author":"Drake","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0225","article-title":"A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with Cabergoline","author":"Stiles","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/11594940-000000000-00000","article-title":"Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study","volume":"35","author":"Trifir\u00f2","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.ando.2021.11.008_bib0235","article-title":"Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study","author":"Beccuti","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2021.11.008_bib0240","first-page":"105","article-title":"Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors","author":"De Sousa","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0245","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2018-02202","article-title":"Dopamine agonist-induced impulse control disorders in patients with prolactinoma: a cross-sectional multicenter study","volume":"104","author":"Dogansen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0250","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1210\/jcem.87.7.8645","article-title":"Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome","volume":"87","author":"Losa","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0255","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","article-title":"Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists","volume":"14","author":"Babey","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2021.11.008_bib0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-10-0961","article-title":"Surgical outcomes and prognostic factors of transsphenoidal surgery for prolactinoma in men: a single-center experience with 87 consecutive cases","volume":"164","author":"Qu","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2021.11.008_bib0265","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/eje.0.1400043","article-title":"Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists?","volume":"140","author":"Turner","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2021.11.008_bib0275","first-page":"125","article-title":"Cost-effectiveness analysis of surgical versus medical treatment of prolactinomas","volume":"78","author":"Zygourakis","year":"2017","journal-title":"J Neurol Surg Part B Skull Base"},{"key":"10.1016\/j.ando.2021.11.008_bib0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.wneu.2015.10.090","article-title":"Cost-effectiveness analysis of microscopic and endoscopic transsphenoidal surgery versus medical therapy in the management of microprolactinoma in the United States","volume":"87","author":"Jethwa","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ando.2021.11.008_bib0285","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","article-title":"Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery","volume":"97","author":"Amar","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2021.11.008_bib0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","article-title":"Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis","volume":"15","author":"Roelfsema","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2021.11.008_bib0295","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.clineuro.2013.02.016","article-title":"Transsphenoidal microsurgical results of female patients with prolactinomas","volume":"115","author":"Ikeda","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ando.2021.11.008_bib0300","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-21-0293","article-title":"Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study","volume":"185","author":"Baussart","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2021.11.008_bib0305","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00701-012-1450-x","article-title":"Transsphenoidal surgery for microprolactinomas in women: results and prognosis","volume":"154","author":"Tamasauskas","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.ando.2021.11.008_bib0310","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-010-0261-4","article-title":"Effect of dopaminergic drug treatment on surgical findings in prolactinomas","volume":"14","author":"Menucci","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2021.11.008_bib0315","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/neuros\/nyy385","article-title":"Endoscopic transsphenoidal surgery of microprolactinomas: a reappraisal of cure rate based on radiological criteria","volume":"85","author":"Micko","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2021.11.008_bib0320","first-page":"123","article-title":"A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years postoperative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.ando.2021.11.008_bib0325","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00701-016-2762-z","article-title":"Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases","volume":"158","author":"Akin","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.ando.2021.11.008_bib0330","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.3390\/cancers13133252","article-title":"Reappraising the role of trans-sphenoidal surgery in prolactin-secreting pituitary tumors","volume":"13","author":"Mattogno","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ando.2021.11.008_bib0335","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fendo.2018.00636","article-title":"The chance of permanent cure for micro- and macroprolactinomas, medication or surgery? A systematic review and meta-analysis","volume":"9","author":"Ma","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ando.2021.11.008_bib0340","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-12-0236","article-title":"Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients","volume":"167","author":"Vroonen","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2021.11.008_bib0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-005-5086-1","article-title":"Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists","volume":"8","author":"Hamilton","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2021.11.008_bib0350","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2265.1987.tb00809.x","article-title":"Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including preoperative bromocriptine therapy","volume":"26","author":"Bevan","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2021.11.008_bib0355","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-58-6-1179","article-title":"Perivascular fibrosis in prolactinomas: is it increased by bromocriptine?","volume":"58","author":"Landolt","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.11.008_bib0360","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/a-1247-4908","article-title":"Outcomes of transsphenoidal microsurgery for prolactinomas\u00a0\u2013\u00a0A contemporary series of 162 cases","volume":"129","author":"Giese","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2021.11.008_bib0365","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-021-01569-6","article-title":"First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center","author":"Andereggen","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2021.11.008_bib0370","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00006123-199902000-00006","article-title":"Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results","volume":"44","author":"Tyrrell","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2021.11.008_bib0375","doi-asserted-by":"crossref","first-page":"6659152","DOI":"10.1155\/2021\/6659152","article-title":"Incidence and factors associated with postoperative delayed hyponatremia after transsphenoidal pituitary surgery: a meta-analysis and systematic review","volume":"2021","author":"Lee","year":"2021","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.ando.2021.11.008_bib0380","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14791\/btrt.2021.9.e5","article-title":"Delayed hyponatremia after transsphenoidal surgery for pituitary adenomas: a single institutional experience","volume":"9","author":"Hong","year":"2021","journal-title":"Brain Tumor Res Treat"},{"key":"10.1016\/j.ando.2021.11.008_bib0385","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2021.11.008_bib0390","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EJE-21-0145","article-title":"Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature","volume":"185","author":"Kuhn","year":"2021","journal-title":"Eur J Endocrinol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426621011033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426621011033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:53:44Z","timestamp":1757717624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426621011033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0003426621011033"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2021.11.008","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative remission of non-invasive lactotroph pituitary tumor: A single-center experience","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2021.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}